Stock Events

Stock Events

Imunon 

$1.8300
79
-$0.06-3.17% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
1.82
Day Low
1.81
52W High
8.19
52W Low
1.7
Volume
624
Avg. Volume
-
Mkt Cap
7.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-5.25
-3.58
-1.92
-0.25
Expected EPS
-0.87
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-14.5MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMNN. It's not an investment recommendation.
NVIDIA
9
NVDA
Amazon
7
AMZN
AMD
6
AMD
Visa
6
V

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that competes with Imunon in the development of treatments for infectious diseases, including HIV and hepatitis, areas where Imunon also aims to innovate.
Merck
MRK
Mkt Cap305.12B
Merck & Co. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including cancer treatments and vaccines, directly competing with Imunon's focus on oncology and immunotherapy.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb operates in the same biopharmaceutical space as Imunon, focusing on cancer, HIV/AIDS, cardiovascular disease, and immune disorders, making it a direct competitor.
AMGEN
AMGN
Mkt Cap196.12B
Amgen is a biotech company focusing on human therapeutics, including treatments for cancer and inflammatory diseases, competing with Imunon's research and development in similar areas.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical corporation that competes with Imunon in the development and marketing of drugs and vaccines for a wide range of diseases, including those targeted by Imunon's pipeline.
Novartis
NVS
Mkt Cap293.94B
Novartis is a global healthcare company that competes with Imunon in developing innovative medicines for various diseases, including cancer and autoimmune diseases, areas of focus for Imunon.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Imunon in the fields of pharmaceuticals and diagnostics, particularly in oncology and immunology.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie is a research-based biopharmaceutical company that competes with Imunon in developing therapies for complex and serious diseases, including cancer and immune-mediated diseases.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson is a diversified healthcare company that competes with Imunon across several areas, including pharmaceuticals and research and development in immunology and oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious medical conditions, competing with Imunon in the area of immunotherapy and targeted cancer treatments.

About

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.
Show more...
CEO
Mr. Michael H. Tardugno
Employees
20
Country
United States
ISIN
US15117N7012

Listings

STU
DE
CBO0.STU
MU
DE
CBO0.MU
F
DE
CBO0.F
LSE
GB
0HUZ.LSE

0 Comments

Share your thoughts

FAQ

What is Imunon stock price today?▼
The current price of IMNN is $1.83 USD — it has decreased by -3.17% in the past 24 hours. Watch Imunon stock price performance more closely on the chart.
What is Imunon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Imunon stocks are traded under the ticker IMNN.
Is Imunon stock price growing?▼
IMNN stock has fallen by -9.41% compared to the previous week, the month change is a +0.55% rise, over the last year Imunon has showed a -74.49% decrease.
What is Imunon market cap?▼
Today Imunon has the market capitalization of 7.69M
When is the next Imunon earnings date?▼
Imunon is going to release the next earnings report on August 06, 2026.
What were Imunon earnings last quarter?▼
IMNN earnings for the last quarter are -0.84 USD per share, whereas the estimation was -1.22 USD resulting in a +30.86% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Imunon revenue for the last year?▼
Imunon revenue for the last year amounts to 0 USD.
What is Imunon net income for the last year?▼
IMNN net income for the last year is -14.5M USD.
How many employees does Imunon have?▼
As of July 18, 2026, the company has 20 employees.
In which sector is Imunon located?▼
Imunon operates in the Health & Wellness sector.
When did Imunon complete a stock split?▼
The last stock split for Imunon was on July 25, 2025 with a ratio of 1:15.
Where is Imunon headquartered?▼
Imunon is headquartered in Lawrenceville, United States.